Effects of 14 weeks of TNF alpha blockade treatment on lipid profile in ankylosing spondylitis

scientific article published on 22 December 2009

Effects of 14 weeks of TNF alpha blockade treatment on lipid profile in ankylosing spondylitis is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/J.JBSPIN.2009.05.012
P698PubMed publication ID20022785

P50authorMartin SoubrierQ58884902
P2093author name stringJean-Jacques Dubost
Sylvain Mathieu
Anne Tournadre
Sandrine Malochet-Guinamand
Jean-Michel Ristori
P433issue1
P304page(s)50-52
P577publication date2009-12-22
P1433published inJoint Bone SpineQ15752403
P1476titleEffects of 14 weeks of TNF alpha blockade treatment on lipid profile in ankylosing spondylitis
P478volume77

Reverse relations

cites work (P2860)
Q38025994Cardiovascular and cerebrovascular diseases in ankylosing spondylitis: current insights
Q38741861Current and future therapies for addressing the effects of inflammation on HDL cholesterol metabolism
Q37405950Effects of anti-TNF-α treatment on lipid profile in rheumatic diseases: an analytical cohort study.
Q38177340Focus on the potential effects of treatments for spondylarthritides on cardiovascular risk
Q38293477Impact of systemic inflammation and autoimmune diseases on apoA-I and HDL plasma levels and functions
Q48003836Impact of treatment with TNF antagonists on total cholesterol in patients with ankylosing spondylitis and psoriatic arthritis
Q35127601Infliximab induces increase in triglyceride levels in psoriatic arthritis patients.
Q36654712Investigation of Cardiac Complications and their Incidence in Patients with Ankylosing Spondylitis
Q38181566Lipid profile changes in patients with rheumatic diseases receiving a treatment with TNF-α blockers: a meta-analysis of prospective studies
Q34418506Psoriasis and comorbidities: links and risks
Q38519523Targeting inflammation in the prevention of cardiovascular disease in patients with inflammatory arthritis.
Q38056160The association between psoriasis and dyslipidaemia: a systematic review
Q37851001Unresolved issues in biologic therapy for rheumatoid arthritis

Search more.